Skip to main content
OpenTrials

Clinical trial condition

Hepatitis B

Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.

720 public trials 60 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis B trial results

Completed

Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder

NCT01847430

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
  • GSK Investigational Site Tuttlingen, Baden-Wurttemberg, Germany
  • GSK Investigational Site Bindlach, Bavaria, Germany
  • GSK Investigational Site Kirchheim, Bavaria, Germany
View Trial Details
Completed

Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children

NCT01138098

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • GSK Investigational Site Banská Bystrica, Slovakia
  • GSK Investigational Site Dolný Kubín, Slovakia
  • GSK Investigational Site Dubnica nad Váhom, Slovakia
  • GSK Investigational Site Martin, Slovakia
View Trial Details
Completed

Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination.

NCT00519649

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations
  • GSK Investigational Site Birkenfeld, Baden-Wurttemberg, Germany
  • GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Heidelberg, Baden-Wurttemberg, Germany
  • GSK Investigational Site Karlsruhe, Baden-Wurttemberg, Germany
View all 35 locations
View Trial Details
Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

NCT01627340

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +14 more
Locations
  • GSK Investigational Site Huntsville, Alabama, United States
  • GSK Investigational Site Stockbridge, Georgia, United States
  • GSK Investigational Site Boise, Idaho, United States
  • GSK Investigational Site Mishawaka, Indiana, United States
View all 22 locations
View Trial Details
Completed

Optimized Treatment and Regression of HBV-induced Early Cirrhosis

NCT01938820

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
Locations
  • Beijing Ditan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • 302 Military Hospital Of China Beijing, Beijing Municipality, China
View all 21 locations
View Trial Details
Completed

Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis

NCT01943617

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
Locations
  • Beijing Ditan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • 302 Military Hospital Of China Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
View all 21 locations
View Trial Details

Related conditions